Literature DB >> 12604230

Purification, characterization and NNK carbonyl reductase activities of 11beta-hydroxysteroid dehydrogenase type 1 from human liver: enzyme cooperativity and significance in the detoxification of a tobacco-derived carcinogen.

Edmund Maser1, Jutta Friebertshäuser, Bernhard Völker.   

Abstract

11beta-Hydroxysteroid dehydrogenase type 1 (11beta-HSD 1) physiologically catalyzes the interconversion of receptor-active 11-hydroxy glucocorticoids (cortisol) to their receptor-inactive 11-oxo metabolites (cortisone), thereby acting as important pre-receptor control device in regulating access of glucocorticoid hormones to the glucocorticoid receptor. Evidence is emerging that 11beta-HSD 1 fulfills an additional role in the detoxification of non-steroidal carbonyl compounds, by catalyzing their reduction to the corresponding hydroxy derivatives that are easier to conjugate and eliminate. Whereas a number of methods were ineffective in purifying 11beta-HSD 1 from human liver, this membrane-bound enzyme was successfully obtained in an active state by a purification procedure that took advantage of a gentle solubilization method as well as providing a favourable detergent surrounding during the various chromatographic steps. We could demonstrate that 11beta-HSD 1 is active as a dimeric enzyme which exhibits cooperativity with cortisone and dehydrocorticosterone (11-oxoreducing activity) as substrates. Accordingly, this enzyme dynamically adapts to low (nanomolar) as well as to high (micromolar) substrate concentrations, thereby providing the fine tuning required as a consequence of great variations in circadian plasma glucocorticoid levels. Due to this kinetic peculiarity, 11beta-HSD 1 is also able to even metabolize nanomolar concentrations of the tobacco-specific nitrosamine 4-methylnitrosamino-1-(3-pyridyl)-1-butanone (NNK), a fact which is important in view of the relatively low levels of this carcinogen observed in smokers. Finally, 11beta-HSD 1 is potently (in nM concentrations) inhibited by glycyrrhetinic acid, the main constituent of licorice. Licorice, however, in addition to being a confectionary, serves as a major cigarette additive, which is used in cigarette manufacturing as a taste and flavour intensifier. Hence, licorice exposure may affect NNK detoxification by inhibition of 11beta-HSD 1, a condition which may advance lung cancer incidence, especially in smokers expressing low levels of this enzyme. Collectively, our data expand insights into the multifunctional nature of hydroxysteroid dehydrogenases/carbonyl reductases and emphasize the importance of 11beta-HSD 1 in the detoxification of a tobacco-derived carcinogen, in addition to its endocrinological functions.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12604230     DOI: 10.1016/s0009-2797(02)00180-1

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  9 in total

Review 1.  The aldo-keto reductase superfamily and its role in drug metabolism and detoxification.

Authors:  Oleg A Barski; Srinivas M Tipparaju; Aruni Bhatnagar
Journal:  Drug Metab Rev       Date:  2008       Impact factor: 4.518

2.  Reductive metabolism of nabumetone by human liver microsomal and cytosolic fractions: exploratory prediction using inhibitors and substrates as marker probes.

Authors:  Kaori Matsumoto; Tetsuya Hasegawa; Junichi Koyanagi; Tamiko Takahashi; Masayuki Akimoto; Kenji Sugibayashi
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2015-06       Impact factor: 2.441

3.  Formation of threohydrobupropion from bupropion is dependent on 11β-hydroxysteroid dehydrogenase 1.

Authors:  Arne Meyer; Anna Vuorinen; Agnieszka E Zielinska; Petra Strajhar; Gareth G Lavery; Daniela Schuster; Alex Odermatt
Journal:  Drug Metab Dispos       Date:  2013-06-26       Impact factor: 3.922

4.  Genetic variability in the metabolism of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) to 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL).

Authors:  Monica Ter-Minassian; Kofi Asomaning; Yang Zhao; Feng Chen; Li Su; Steven G Carmella; Xihong Lin; Stephen S Hecht; David C Christiani
Journal:  Int J Cancer       Date:  2011-08-03       Impact factor: 7.396

5.  NNK promotes migration and invasion of lung cancer cells through activation of c-Src/PKCι/FAK loop.

Authors:  Jie Shen; Lijun Xu; Taofeek K Owonikoko; Shi-Yong Sun; Fadlo R Khuri; Walter J Curran; Xingming Deng
Journal:  Cancer Lett       Date:  2011-12-13       Impact factor: 8.679

6.  Bupropion metabolism by human placenta.

Authors:  Xiaoming Wang; Doaa R Abdelrahman; Olga L Zharikova; Svetlana L Patrikeeva; Gary D V Hankins; Mahmoud S Ahmed; Tatiana N Nanovskaya
Journal:  Biochem Pharmacol       Date:  2010-01-28       Impact factor: 5.858

Review 7.  11β-hydroxysteroid dehydrogenases: intracellular gate-keepers of tissue glucocorticoid action.

Authors:  Karen Chapman; Megan Holmes; Jonathan Seckl
Journal:  Physiol Rev       Date:  2013-07       Impact factor: 37.312

8.  Stress hormones promote DNA damage in human oral keratinocytes.

Authors:  Vitor Bonetti Valente; Diovana de Melo Cardoso; Giseli Mitsuy Kayahara; Giovana Barros Nunes; Kellen Cristine Tjioe; Éder Ricardo Biasoli; Glauco Issamu Miyahara; Sandra Helena Penha Oliveira; Gisele Zoccal Mingoti; Daniel Galera Bernabé
Journal:  Sci Rep       Date:  2021-10-05       Impact factor: 4.379

9.  Metabolism of F18, a Derivative of Calanolide A, in Human Liver Microsomes and Cytosol.

Authors:  Xiangmeng Wu; Qinghao Zhang; Jiamei Guo; Yufei Jia; Ziqian Zhang; Manman Zhao; Yakun Yang; Baolian Wang; Jinping Hu; Li Sheng; Yan Li
Journal:  Front Pharmacol       Date:  2017-07-19       Impact factor: 5.810

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.